Clough Capital Partners Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
APLS
Apellis Pharmaceuticals
APLS
|
+$13.5M |
| 2 |
Microchip Technology
MCHP
|
+$10.8M |
| 3 |
Equinix
EQIX
|
+$10.7M |
| 4 |
American Tower
AMT
|
+$10.5M |
| 5 |
GoDaddy
GDDY
|
+$9.38M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lam Research
LRCX
|
+$33.1M |
| 2 |
Apple
AAPL
|
+$31.3M |
| 3 |
D.R. Horton
DHI
|
+$27M |
| 4 |
Yelp
YELP
|
+$26.6M |
| 5 |
Broadcom
AVGO
|
+$21.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.97% |
| 2 | Financials | 21.71% |
| 3 | Consumer Discretionary | 17.91% |
| 4 | Healthcare | 16.25% |
| 5 | Real Estate | 11.2% |
Similar funds
Clough Capital Partners's Q4 2017 Portfolio in Review
As of Q4 2017, Clough Capital Partners held 162 positions worth $1.2B, down 20% from $1.49B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Clough Capital Partners withdrew a net $360M in Q4 2017, closing 29 positions and reducing 54 holdings. Its most notable exit was Yelp, an estimated $26.6M position sold in full.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 23% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Clough Capital Partners opened a new position in Apellis Pharmaceuticals worth $19.7M.
- Clough Capital Partners's largest Q4 2017 buy was Apellis Pharmaceuticals: 917,116 shares worth $19.7M.
- Clough Capital Partners added most to Wayfair in Q4 2017, an estimated $8.01M increase.
- Clough Capital Partners's biggest Q4 2017 reduction was Lam Research, cutting an estimated $33.1M.
- Clough Capital Partners fully exited Yelp in Q4 2017, selling an estimated $26.6M.
- Clough Capital Partners's ten largest holdings make up 36% of its $1.2B portfolio in Q4 2017.
- Clough Capital Partners opened 39 new positions and closed 29 in Q4 2017.
- Clough Capital Partners's portfolio value fell 20% quarter-over-quarter to $1.2B.
Based on Clough Capital Partners's 13F filing for Q4 2017, filed 14 Feb 2018.